|
|
|
 |
Press Releases
Fri Feb 4, 2010
- ImmunoCellular Therapeutics to Present at 12th Annual BIO CEO & Investor Conference on Tuesday, February 9th
Wed Jan 20, 2010
- New Study Shows ImmunoCellular Therapeutics' Lead Investigational Cancer Vaccine ICT-107 Targets Cancer Stem Cells
Fri Jan 8, 2010
- ImmunoCellular Therapeutics, Ltd. To Present at the OneMedForum and the Biotech Showcase Next Week
2009 Press Releases
Fri Dec 11, 2009
- ImmunoCellular Therapeutics Announces Key Additions to Scientific Advisory Board
Mon Dec 7, 2009
- ImmunoCellular Therapeutics Receives $10 Million Financing Commitment
Wed Dec 2, 2009
- ImmunoCellular Therapeutics Enters into Option Agreement with The University of Texas M. D. Anderson Cancer Center for a Novel Cancer Stem Cell Therapy
Tue Dec 1, 2009
- ImmunoCellular Therapeutics to Present at LD Micro Conference on December 3rd
Thu Nov 19, 2009
- ImmunoCellular Therapeutics Issues Letter to Shareholders
Tue Nov 17, 2009
- Griffin Securities Reiterates Buy Rating of ImmunoCellular Therapeutics
Tue Oct 27, 2009
- ImmunoCellular Therapeutics Presents Data from Phase I Trial of ICT-107 Demonstrating Significant Increase in Tumor-Free Progression in Patients with Brain Cancer
Thur Oct 22, 2009
- ImmunoCellular Therapeutics Engages Dr. Peter Brooks of the Maine Medical Center to Explore Cancer Stem Cell Targets
Mon Oct 19, 2009
- ImmunoCellular Therapeutics Applies for Key Patent Relating to Novel Antigen Targets for Its Monoclonal Antibody Product Candidate
Wed Sept 30, 2009
- ImmunoCellular Therapeutics' Antibody Shows Promise in Detecting Pancreatic and Lung Cancer in Serum Test
Wed Sept 23, 2009
- ImmunoCellular Therapeutics Announces Successful Humanization of Two Antibody Candidates
Thu Sept 17, 2009
- ImmunoCellular Therapeutics' Immunology Platform Featured in Report on the Future of Cancer Research
Wed Sept 9, 2009
- ImmunoCellular Therapeutics Enters into Research and License Option Agreement with Roche Group
Thu Sept 3, 2009
- ImmunoCellular Therapeutics To Present at Rodman and Renshaw's 11th Annual Healthcare Conference on Friday, September 11th
Tue Aug 18, 2009
- ImmunoCellular Therapeutics to Present at Southern California Investor Conference
Tue July 14, 2009
- ImmunoCellular Therapeutics Retains Services of Torrey Pines Institute for Molecular Studies and Renowned Immunologist to Evaluate Lead Product Candidate
Mon June 29, 2009
- ImmunoCellular Therapeutics Announces Issuance of Japanese Patent Covering Its Lead Antibody Product Candidate ICT-109 For Treatment of Small Cell Lung Cancer
Wed June 24, 2009
- ImmunoCellular Therapeutics Signs Manufacturing Agreement with Formatech for Clinical Trial of ICT-121 Immunotherapy
Thu June 18, 2009
- ImmunoCellular Therapeutics Announces Filing of Key Patent Application Relating to Cancer Stem Cell Technology
Thu June 4, 2009
- ImmunoCellular Therapeutics Reports Additional Data from Promising Brain Cancer Clinical Trial
Tue May 26, 2009
- Clinical Data from Trial of ImmunoCellular Therapeutics' Cancer Vaccine ICT-107 to Be Presented at ASCO 2009 Annual Meeting
Tue Mar 31, 2009
- ImmunoCellular Therapeutics Provides Update on Progress of Key Programs, Including 2008 Financial Results
Tue Mar 10, 2009
- Immunocellular Theraputics Signs Agreement with Formatech for Development of Cancer Stem Cell Vaccine Formulation
Tue Feb 24, 2009
- Immunocellular Theraputics Identifies Novel Peptides to Broaden Applicability of Cancer Stem Cell Vaccine
2008 Press Releases
Tue Dec 23, 2008
- ImmunoCellular Therapeutics Cancer Vaccine Demonstrates Immune Response against Brain Cancer in Clinical Trial
Wed Nov 5, 2008
- ImmunoCellular Therapeutics Announces Webcast Presentation at Rodman & Renshaw 10th Annual Healthcare Conference
Tue Oct 21, 2008
- Immunocellular Theraputics Granted Patents Covering Its Lead Monoclonal Antibody Cancer Product Candidate
Tue Oct 14, 2008
- ImmunoCellular Therapeutics Appoints Drs. Peter Brooks and Sherie Morrison to Scientific Advisory Board
Thu Oct 9, 2008
- ImmunoCellular Therapeutics Announces Filing of Patent Application for a Novel Cancer Stem Cell Vaccine Technology
Tue Sept 23, 2008
- ImmunoCellular Therapeutics Elects Dr. James Bender to Position of Vice President, Clinical Development
Wed July 23, 2008
- ImmunoCellular Therapeutics Signs Agreement with Antitope for Humanization of Antibody Product Candidates
Wed July 9, 2008
- ImmunoCellular Therapeutics Licenses Additional Cancer Stem Cell Technologies from Cedars-Sinai
Wed June 25, 2008
- ImmunoCellular Therapeutics Elects Dr. Navdeep Jaikaria to Board of Directors
Thu June 19, 2008
- Immunocellular Theraputics Announces Research Agreement with George Mason University for Detection of Certain Cancers
Wed June 11, 2008
- Immunocellular Theraputics to Present at Bio International Convention
Wed May 28, 2008
- Immunocellular Theraputics Announces Ability to Characterize Distinct Antigens Between Cancers Using Monoclonal Antibody Technology
Wed May 21, 2008
- Immunocellular Therapeutics Announces Completion of Proof-of-Principle Studies Demonstrating Efficacy of Cancer Stem Cell Vaccine in Preclinical Model
Tue May 13, 2008
- ImmunoCellular Therapeutics To Present at the Biotech/Pharma/Healthcare Informed Investors Forum
Wed March 26, 2008
- ImmunoCellular Therapeutics to Host Webcast Conference Call
Thu February 21, 2008
- ImmunoCellular Therapeutics Announces New President and Chief Executive Officer
Fri February 15, 2008
- ImmunoCellular Therapeutics Completes Acquisition of Molecular Antibody Technology
2007 Press Releases
Tue November 26, 2007
- ImmunoCellular Therapeutics to Hold Investor Conference Call
Tue November 26, 2007
- ImmunoCellular Therapeutics Agrees to Acquire Molecular Antibody Technology
Tue November 13, 2007
- ImmunoCellular Therapeutics Names Interim President, Files Key Patent Applications
Thu August 2, 2007
- IMUC Updates Brain Tumor Vaccine Program Status; First Three Patients Enrolled
|
|
|
